Pradaxa 30 mg/1 (Dabigatran Etexilate PELLET) 30 mg/1

Pradaxa 30 mg/1 is an oral pellet formulation of dabigatran etexilate, used for blood thinning and clot prevention. This medication is manufactured by Boehringer Ingelheim Pharmaceuticals, Inc. in the USA.

Strength

30 mg/1

Pack Size

1 BAG in 1 CARTON (0597-0430-18) / 60 PELLET in 1 BAG

Manufacturer / TM Owner

Boehringer Ingelheim Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Pradaxa 30 mg/1 is primarily used for blood thinning to prevent blood clots. It is often prescribed for conditions where reducing the risk of clot formation is crucial. The medication works by inhibiting certain clotting factors in the blood, helping to maintain blood flow and reduce the risk of stroke or heart attack. What is Pradaxa used for? It is commonly used in the management of atrial fibrillation and other conditions requiring anticoagulation therapy.

Side Effects

Common effects of Pradaxa 30 mg/1 may include bleeding more easily than usual. Some users might experience bruising, nosebleeds, or prolonged bleeding from cuts. It is important to monitor for any signs of unusual bleeding and consult a healthcare provider if such effects are observed.

Precautions & Warnings

Pradaxa 30 mg/1 should be handled with care, especially in individuals with a history of bleeding disorders or stomach ulcers. It is crucial to follow the prescribed dosage and administration instructions. Regular monitoring may be necessary to ensure the medication is working as intended and to avoid potential complications.

Avoid Interactions

Pradaxa 30 mg/1 may interact with other medications, including certain pain relievers, anticoagulants, and antiplatelet drugs. Alcohol consumption should be moderated, as it can increase the risk of bleeding. Always inform healthcare providers about all medications and supplements being taken to avoid potential interactions.

Frequently Asked Questions

Pradaxa is used for blood thinning to prevent blood clots, often in conditions like atrial fibrillation.

Pradaxa 30 mg/1 is an oral pellet formulation taken by mouth. Follow the healthcare provider's instructions for proper administration.

Common side effects may include increased bleeding, bruising, and nosebleeds. Monitor for unusual bleeding and consult a healthcare provider if observed.

Yes, Pradaxa may interact with pain relievers, anticoagulants, and antiplatelet drugs. Always inform healthcare providers about all medications being taken.

Pradaxa should be used with caution in individuals with bleeding disorders or stomach ulcers. Consult a healthcare provider for personalized advice.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.